The European Medicines Agency on Thursday recommended granting conditional marketing authorisation to the Covid-19 vaccine of pharmaceutical company Johnson & Johnson, in people 18 years old and upwards. This is the first vaccine which can be used as a single dose. Clinical trials showed that the vaccine had a 67-percent efficacy.
Britain has rejected claims from the European Council president Charles Michel, who accused the UK of imposing a ban on vaccine exports. Meanwhile, one-third of vaccines produced in the EU last month were exported to the UK.